ANTONIO
CASADO HERRÁEZ
Profesor asociado de Ciencias de la Salud
Publicaciones (157) Publicaciones de ANTONIO CASADO HERRÁEZ
2024
2023
-
Evaluación del Miedo a la Recurrencia del cáncer en español: el Cuestionario de Miedo a la Recurrencia del Cáncer y Escala General del Miedo a la Recurrencia del Cáncer: un estudio piloto
Psicooncología: investigación y clínica biopsicosocial en oncología, Vol. 20, Núm. 1, pp. 155-173
2022
-
Efficacy and safety of olaparib according to age in BRCA1/2-mutated patients with recurrent platinum-sensitive ovarian cancer: Analysis of the phase III SOLO2/ENGOT-Ov21 study
Gynecologic Oncology, Vol. 165, Núm. 1, pp. 40-48
2021
-
A European, Observational, Prospective Trial of Trabectedin Plus Pegylated Liposomal Doxorubicin in Patients with Platinum-Sensitive Ovarian Cancer
Oncologist, Vol. 26, Núm. 4, pp. e658-e668
-
Complete Spontaneous Regression of Lung Metastases after Resection of CIC-Rearranged Sarcoma: A Case Report
Case Reports in Oncology, Vol. 14, Núm. 1, pp. 152-159
-
Cáncer ginecológico en la anciana
Revisiones en Cancer, Vol. 35, Núm. 5, pp. 209-217
-
Incorporating the patient voice in sarcoma research: How can we assess health-related quality of life in this heterogeneous group of patients? a study protocol
Cancers, Vol. 13, Núm. 1, pp. 1-14
-
Inflammatory myofibroblastic tumour of an unusual presentation in the uterine cervix: a case report
World Journal of Surgical Oncology, Vol. 19, Núm. 1
-
SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)
Clinical and Translational Oncology, Vol. 23, Núm. 5, pp. 922-930
2020
-
A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113)
International Journal of Gynecological Cancer, Vol. 30, Núm. 10, pp. 1633-1637
-
Are antiangiogenics a good ‘partner’ for immunotherapy in ovarian cancer?
Angiogenesis, Vol. 23, Núm. 4, pp. 543-557
-
Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors
Frontiers in Oncology, Vol. 9
-
Practical clinical guidelines of the EOTTD for treatment and referral of gestational trophoblastic disease
European Journal of Cancer, Vol. 130, pp. 228-240
2019
-
Multicenter retrospective study to evaluate the impact of trabectedin plus pegylated liposomal doxorubicin on the subsequent treatment in women with recurrent, platinum-sensitive ovarian cancer
Anti-Cancer Drugs, Vol. 30, Núm. 6, pp. 628-635
-
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: Pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials
Obstetrical and Gynecological Survey
-
Trabectedin for reversing platinum resistance and resensitization to platinum in patients with recurrent ovarian cancer
Future Oncology, Vol. 15, Núm. 3, pp. 271-280
-
Una revisión sistemática de las recomendaciones diagnósticas y terapéuticas del panel de expertos en cáncer de origen desconocido
Archivos de medicina, Vol. 15, Núm. 1
2018
-
Correction to: Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling (Breast Cancer Research and Treatment, (2018), 171, 3, (627-634), 10.1007/s10549-018-4855-2)
Breast Cancer Research and Treatment
-
Expression III: Patients' expectations and preferences regarding physician-patient relationship and clinical management-results of the international NOGGO/ ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countries
Annals of Oncology, Vol. 29, Núm. 4, pp. 910-916
-
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials
The Lancet Oncology, Vol. 19, Núm. 12, pp. 1680-1687